You are here: Products\Immunoassays\Interleukin-10 Human ELISA:

Interleukin-10 Human ELISA

Product of BioVendor
Other names: IL-10, Cytokine synthesis inhibitory factor, B cell derived T cell growth factor, Mast cell growth factor III
Cat. No.: ROIL10001R Regulatory status: RUO
Size: 96 wells (1 kit) |
Files: Datasheet PDF (RUO) MSDS (RUO)
Legend: new product new product
discount discount
temporarily out of stock temporarily out of stock
book in advance order in advance

Research topic

Cytokines and Chemokines and related molecules

Storage/Shipping

+4°C/ Wet ice

Summary

IL-10 is an immunoregulatory protein produced by a number of cell lineages, including TH2 cells, B-cells and activated monocytes. Il-10 is an important factor in understanding autoimmunity and as a target molecule in the development of anti-rejection therapies.

Assay format

Sandwich ELISA, Biotin-labelled antibody

Sample requirements

50 µl/well

Applications

Cell culture medium, Plasma-Citrate, Plasma-Heparin, Serum, Urine

Calibration Curve

Calibration range

7.8 to 500 pg/ml

Limit of detection

2 pg/ml

Spiking Recovery

2 pg/ml

Cross-Reactivity

No cross reactivity was observed with the following recombinant human proteins: IL-1α, IL-1β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-12, IL-13, TNF α, TARC.

References to summary

  • Greig P et al.: Elevated amniotic fluid interleukin-10 concentrations increase through pregnancy are elevated in patients with preterm labor associated with intrauterine infection. Amer. J. Obstet. Gynecol. 173, 1223–1227 (1995).
  • Howard, M et al.: Biological properties of interleukin 10. J. Clin. Immunol. 12:239–247 (1992).
  • Komorowski, J et al.: Cytokine serum levels as the markers of thyroid activation in Graves' disease. Immunol. Lett. 60, 143–148 (1998).
  • Koziel MJ et al.: HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cyokine release. J. Clin. Invest. 96, 2311–2321 (1995).
  • Platz K et al.: Cytokine pattern during rejection and infection after liver transplantation – improvements in postoperative monitoring?Tran­splantation 62, 1441–1450 (1996).
  • Schultze JL et al.: CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen- specific T cells for adoptive immunotherapy.J. Clin. Invest. 100, 2757–2765 (1997).
  • Vieira P et al.: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.Proc. Natl. Acad. Sci. USA 88:172–176 (1991).
  • Whitcup SM et al.: Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.Arch. Ophthalmol. 115, 1157–1160 (1997).
  • Zhang Y et al.: Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloprotei­nases.J. CLin. Invest. 99, 894–900 (1997).


Shopping cart

Your cart is empty.